51 Firmen mit Ergebnissen für "怎么查酒店开房信息- 查询微信17 1"

University of Zurich

https://www.campus-schlieren.uzh.ch/en.html  

8952 Schlieren, Wagistrasse 12

The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.

University of Zurich

Wagistrasse 12

8952 Schlieren

12299 Ergebnisse für "怎么查酒店开房信息- 查询微信17 1" unter University of Zurich

Microsoft Word - 05_2007101800709203_FullPaper_查.doc

... , Michael.Schaepman, Jan.Clevers)@wur.nl Commission VII, WG VII/ 1 KEY WORDS: Chlorophyll Content, Non-Photosynthetic ... . * Corresponding author. 1. INTRODUCTION Foliar concentration of the main photosynthetic pigments chlorophyll a and ... , Michael.Schaepman, Jan.Clevers)@wur.nl Commission VII, WG VII/ 1 KEY WORDS: Chlorophyll Content, Non-Photosynthetic ... . * Corresponding author. 1. INTRODUCTION Foliar concentration of the main photosynthetic pigments chlorophyll a and ... Microsoft Word - 05_2007101800709203_FullPaper_ .doc ...

Slide 1

... Slide 1 8th Winter Brain Symposium, Sils Maria Program at a Glance Time Sunday, February 26 Monday ... , bavarian curling, skating, snow shoe tour 16:20- 17:00 individual meetings Chair: C. Hock Chair: R. Vassar ... Slide 1 ... Slide 1 8th Winter Brain Symposium, Sils Maria Program at a Glance Time Sunday, February 26 Monday ... Slide 1 ...

Mehr Ergebnisse

ETH Entrepreneurship

https://ethz.ch/en/industry/entrepreneurship.html  

8952 Schlieren, Wagistrasse 18


 entrepreneurship@ethz.ch

Excellence in entrepreneurship at ETH Zurich is driven by world-​class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions. 

ETH Entrepreneurship

Wagistrasse 18

8952 Schlieren

8694 Ergebnisse für "怎么查酒店开房信息- 查询微信17 1" unter ETH Entrepreneurship

Slide 1

... = 50kHz ± 20kHz   8/ 17 ► 5 Years Ago … ■ Example of Highly-Compact 1-Ф PFC Rectifier ■ Two Interleaved ... Slide 1 Johann W. Kolar Swiss Federal Institute of Technology (ETH) Zurich Power Electronic Systems ... = 50kHz ± 20kHz   8/ 17 ► 5 Years Ago … ■ Example of Highly-Compact 1-Ф PFC Rectifier ■ Two Interleaved ... Slide 1 ... Slide 1 ...

Slide 1

... , January 2012 D1 D2 ϕ uFB1 uFB2 iFB1 10/ 17 ► Modulation Scheme (II) ( 1) Triangular Current Mode (TCM) uFB1 ... Slide 1 1/xy Bidirectional Isolated DC/DC Converter with Wide Input Voltage Range for Residential ... , January 2012 D1 D2 ϕ uFB1 uFB2 iFB1 10/ 17 ► Modulation Scheme (II) ( 1) Triangular Current Mode (TCM) uFB1 ... Slide 1 ... Slide 1 ...

Mehr Ergebnisse

Blutspende SRK Zürich

https://www.blutspendezuerich.ch/  

8952 Schlieren, Rütistrasse 19

 +41 58 272 52 52
 info@zhbsd.ch

The Zurich Blood Transfusion Service SRK (ZHBSD) is a nonprofit foundation and independent partner in the healthcare sector. It ensures the supply of blood and blood products to patients in the Zurich region. Our products are made exclusively from voluntary, unpaid blood donations. We offer our services at cost-covering prices and without government subsidies. Along with ten other regional blood donation services in Switzerland, we are a member of the Swiss Red Cross Blood Donation Service (BSD SRK AG).

Blutspende SRK Zürich

Rütistrasse 19

8952 Schlieren

304 Ergebnisse für "怎么查酒店开房信息- 查询微信17 1" unter Blutspende SRK Zürich

Folie 1

... 5 of 17 (29%) to 1 of 17 (6%) by the presented analysis in DAU positive individuals. However, some ... *DAU3 | RHD*01N.01 + - 1 1 RHD*DAU | RHD*01 + + RHD*DAU5 | RHD*01 + + 17 11(9) 6 Swisstransfusion ... 5 of 17 (29%) to 1 of 17 (6%) by the presented analysis in DAU positive individuals. However, some ... *DAU3 | RHD*01N.01 + - 1 1 RHD*DAU | RHD*01 + + RHD*DAU5 | RHD*01 + + 17 11(9) 6 Swisstransfusion ... Folie 1 ...

Folie 1

... Folie 1 PATHOGEN INACTIVATION OF PLASMA WITH THE INTERCEPT BLOOD SYSTEM – EXPERIENCES FROM ROUTINE ... are the set’s upper limit. Excess plasma is discarded (Fig. 1). Therefore, proper pooling of recovered ... Folie 1 ... Folie 1 PATHOGEN INACTIVATION OF PLASMA WITH THE INTERCEPT BLOOD SYSTEM – EXPERIENCES FROM ROUTINE ... Folie 1 ...

Mehr Ergebnisse

University Hospital Zurich​, Research and Education Office

https://www.usz.ch/forschung/Seiten/default.aspx  

8091 Zürich, Rämistrasse 100

The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.

University Hospital Zurich​, Research and Education Office

Rämistrasse 100

8091 Zürich

844 Ergebnisse für "怎么查酒店开房信息- 查询微信17 1" unter University Hospital Zurich​, Research and Education Office

1 Summary

... 1 Summary Background: According to the WHO/EORTC classification, primary cutaneous diffuse large B ... cases were reviewed, upon which 17 cases with insufficient material, 30 patients with a previous ... 1 Summary ... 1 Summary Background: According to the WHO/EORTC classification, primary cutaneous diffuse large B ... 1 Summary ...

Slide 1

... Slide 1 Changes in autopsy rates among cancer patients and its impact from the public health point ... of view Uwe Bieri1, Holger Moch2, Silvia Dehler3, Dimitri Korol3, Sabine Rohrmann1 1 Division of ... Slide 1 ... Slide 1 Changes in autopsy rates among cancer patients and its impact from the public health point ... Slide 1 ...

Mehr Ergebnisse

Somagenetix

https://www.wysszurich.ch/projects/somagenetix  

8952 Schlieren, Wagistrasse 23

Gene therapy solutions for patients with severe inherited diseases.

Somagenetix

Wagistrasse 23

8952 Schlieren

21726 Ergebnisse für "怎么查酒店开房信息- 查询微信17 1" unter Somagenetix

Folie 1

... Folie 1 U N I V E R S I T Ä T S M E D I Z I N B E R L I N Sex in basic research – concepts in the ... 0 1 2 3 4 Years after AVR 0.8 1 0.6 0.4 0.2 Su rv iv al (% ) 0 Type of LV hypertrophic remodeling ... Folie 1 ... Folie 1 U N I V E R S I T Ä T S M E D I Z I N B E R L I N Sex in basic research – concepts in the ... Folie 1 ...

pone.0025506 1..17

... pone.0025506 1.. 17 Zurich Open Repository and Archive University of Zurich University Library ... by a TH grant of the ETH Zurich (TH-03 06- 1), and R.H. was supported by the Swiss National Science ... pone.0025506 1.. 17 ... pone.0025506 1.. 17 Zurich Open Repository and Archive University of Zurich University Library ... pone.0025506 1.. 17 ...

Mehr Ergebnisse

Roche Glycart AG

https://www.roche.ch/en/sites/schlieren  

8952 Schlieren, Wagistrasse 10

 +41 43 215 10 00

The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.

Roche Glycart AG

Wagistrasse 10

8952 Schlieren

2709 Ergebnisse für "怎么查酒店开房信息- 查询微信17 1" unter Roche Glycart AG

OP-EHEA190412 1..61

... OP-EHEA190412 1..61 2019 ESC Guidelines for the diagnosis and management of acute pulmonary ... Mainz, Building 403, Langenbeckstr. 1, 55131 Mainz, Germany. Tel: þ49 613 117 6255, Fax: þ49 613 117 ... OP-EHEA190412 1..61 ... OP-EHEA190412 1..61 2019 ESC Guidelines for the diagnosis and management of acute pulmonary ... OP-EHEA190412 1..61 ...

1

... 1 ... 1 Science Culture Community Participate Go to roche.com Science Culture Community Participate Go to ... 1 ...

Mehr Ergebnisse

Bio-Technopark Schlieren-Zürich

http://www.bio-technopark.ch/  

8952 Schlieren, Wagistrasse 23

 +41 76 336 99 44
 mario.jenni@bio-technopark.ch

The Bio-Technopark offers professional support for life science start-ups in the setting up and expansion of business activities and promotes interaction between start-ups, academia and industry. A nationally and internationally respected science park has grown up at Schlieren. Through stringent selection, coaching and support, more than 30 successful start-up companies with 750 employees are located here. Eight have been acquired by large corporates, but are still active in the park. Together with 20 institutes and clinics from the University and University Hospital Zurich, an innovative mix of very young and well-established companies and academic research groups has emerged.

Bio-Technopark Schlieren-Zürich

Wagistrasse 23

8952 Schlieren

136 Ergebnisse für "怎么查酒店开房信息- 查询微信17 1" unter Bio-Technopark Schlieren-Zürich

1. Digital Health Lab Day › BIO-TECHNOPARK® Schlieren-Zürich

... 1. Digital Health Lab Day Event date: 03.10.2019 1. Digital Health Lab Day – Life in numbers 5 on ... 1. Digital Health Lab Day › BIO-TECHNOPARK® Schlieren-Zürich ... https://www.bio-technopark.ch/en/events-en/external-events/ 1-digital-health-lab-day/ ... 1. Digital Health Lab Day › BIO-TECHNOPARK® Schlieren-Zürich ...

Molecular Partners Announces First Patient Dosed in Phase 1 Trial o...

... News Molecular Partners Announces First Patient Dosed in Phase 1 Trial of MP0310, a Novel Tumor ... announced that the first patient has been enrolled and dosed in a Phase 1 first-in-human study of MP0310 as ... Molecular Partners Announces First Patient Dosed in Phase 1 Trial of MP0310, a Novel Tumor ... - 1-trial-of-mp0310-a-novel-tumor-localized-immunotherapy/ ... Molecular Partners Announces First Patient Dosed in Phase 1 Trial of MP0310, a Novel Tumor ...

Mehr Ergebnisse

Neurimmune Therapeutics AG

http://www.neurimmune.com  

8952 Schlieren, Wagistrasse 18

 +41 44 755 46 46
 info@neurimmune.com

Neurimmune is a biopharmaceutical company dedicated to the development of immunotherapeutics for the treatment and prevention of human disorders with a focus on protein aggregation diseases.

Neurimmune Therapeutics AG

Wagistrasse 18

8952 Schlieren

77 Ergebnisse für "怎么查酒店开房信息- 查询微信17 1" unter Neurimmune Therapeutics AG

Neurimmune - 19.02.2017: BIIB076 Moves into Phase 1 for Alzheimer's...

... February 19, 2017 BIIB076 Moves into Phase 1 for Alzheimer's Disease BIIB076 has moved into phase 1 ... Neurimmune - 19.02.2017: BIIB076 Moves into Phase 1 for Alzheimer's Disease ... http://www.neurimmune.com/newsartikel/19022017-biib076-moves-into-phase- 1-for-alzheimers ... Neurimmune - 19.02.2017: BIIB076 Moves into Phase 1 for Alzheimer's Disease ...

Neurimmune - 07.03.2013: Biogen presents the first clinical data fr...

... Neurimmune March 7, 2013 Biogen presents the first clinical data from an ongoing Phase 1 study of ... clinical data from an ongoing Phase 1 trial, as well as new data on a direct comparison of mouse versions ... Neurimmune - 07.03.2013: Biogen presents the first clinical data from an ongoing Phase 1 study of ... -ongoing-phase- 1-study-of-biib037-in-mild-to-moderate-alzheimers.html ... Neurimmune - 07.03.2013: Biogen presents the first clinical data from an ongoing Phase 1 study of ...

Mehr Ergebnisse

InSphero AG

http://www.insphero.com  

8952 Schlieren, Wagistrasse 27

 +41 44 515049-0
 info@insphero.com

InSphero is a leading supplier of organotypic, biological in vitro 3D microtissues for highly predictive drug testing. The company currently counts all of the top ten global pharmaceutical and cosmetics companies as customers and is helping them to implement its patented microtissue technology in their development work-flow.

InSphero AG

Wagistrasse 27

8952 Schlieren

280 Ergebnisse für "怎么查酒店开房信息- 查询微信17 1" unter InSphero AG

Slide 1

... Slide 1 1 1 0 1 0 0 1 0 0 0 0 5 0 1 0 0 1 5 0 2 0 0 S ita x s e n ta n (µ M ) C e ll v ia b il it y ... 0 = M4 32 .8 IC 5 0 = M1 90 .9 IC 5 0 = M3 48 . 1 H u m a n H e p /H u m a n N P C 1 1 0 1 0 0 1 0 ... Slide 1 1 1 0 1 0 0 1 0 0 0 0 5 0 1 0 0 1 5 0 2 0 0 S ita x s e n ta n (µ M ) C e ll v ia b il it y ... 0 = M4 32 .8 IC 5 0 = M1 90 .9 IC 5 0 = M3 48 . 1 H u m a n H e p /H u m a n N P C 1 1 0 1 0 0 1 0 ... Slide 1 ...

Folie 1

... Folie 1 INTRODUCTION Defeating the animal: Alternative systems for neurotoxicity testing Julia ... Leist2, Christoph van Thriel1 1 IfADo, Dortmund, Germany 2 University of Konstanz, Konstanz, Germany 3 ... Folie 1 INTRODUCTION Defeating the animal: Alternative systems for neurotoxicity testing Julia ... Leist2, Christoph van Thriel1 1 IfADo, Dortmund, Germany 2 University of Konstanz, Konstanz, Germany 3 ... Folie 1 ...

Mehr Ergebnisse

Kuros Biosciences AG

https://kurosbio.com/  

8952 Schlieren, Wagistrasse 25

 +41 (0)44 733 4747

Our focus is on revolutionizing the field of orthobiologics by developing bone grafts that deliver both targeted and controlled bone healing.

Kuros Biosciences AG

Wagistrasse 25

8952 Schlieren

133 Ergebnisse für "怎么查酒店开房信息- 查询微信17 1" unter Kuros Biosciences AG

Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs M...

...  MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft Schlieren (Zurich ... announced the publication of a peer-reviewed manuscript that details the clinical data of its MAXA Level 1 ... Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in ... -maxa-level- 1-study-outcomes-in-spine-indicating-superiority-over-autograft/ ... Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in ...

Comments on: Kuros Biosciences completes enrolment in Level 1 clini...

... Comments on: Kuros Biosciences completes enrolment in Level 1 clinical study of MagnetOs Granules ... Comments on: Kuros Biosciences completes enrolment in Level 1 clinical study of MagnetOs Granules ... Comments on: Kuros Biosciences completes enrolment in Level 1 clinical study of MagnetOs Granules ... https://kurosbio.com/resources/kuros-biosciences-completes-enrolment-in-level- 1-clinical-study-of ... Comments on: Kuros Biosciences completes enrolment in Level 1 clinical study of MagnetOs Granules ...

Mehr Ergebnisse

Mehr Firmen

Nach oben